Abstract
Progressive multifocal leukoencephalopathy (PML) usually is a rapid and fatal demyelinating disease of the central nervous system (CNS), caused by JC virus (JCV). After the introduction of Highly active antiretroviral therapy (HAART), its prognosis has been modified in some cases but remains a relevant cause of morbidity in human immunodeficiency virus-seropositive (HIV+) patients. The authors report here two cases of PML, followed over time, sharing a benign course and a JCV antigen-specific T-cell response, but with different cerebrospinal fluid (CSF), magnetic resonance imaging (MRI), and clinical features. In both cases, JCV DNA detection in brain biopsies samples and specific antigenic response preceded its isolation in the CSF by several months. In one patient, during the first stage of the disease, the presence of CSF and MRI inflammatory findings, associated with the lack of JCV detection in the CSF, made the diagnosis more challenging. Given that to date a reformation of the laboratory parameters for PML diagnosis is strongly needed, this report highlights the following considerations: (a) indications for performing brain biopsy in HIV-related leukoencephalopathies of uncertain origin, and (b) the role of JCV immunologically specific T-cell response as an additional marker for PML diagnosis and indicator for good prognosis of the disease.
This is a preview of subscription content, log in via an institution to check access.
References
Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A (2001). Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J NeuroVirol 7: 323–328.
Berger JR, Major EO (1999). Progressive multifocal leukoencephalopathy. Semin Neurol 19: 193–200.
Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Sala S, Lazzarin A, Cinque P (2005). Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 40: 738–744.
Clerici M, Saresella M, Trabattoni D, Speciale L, Fossati S, Ruzzante S, Cavaretta R, Filippi M, Caputo D, Ferrante P (2001). Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol 121: 88–101.
Clifford DB, Yiannoutsos C, Glicksman M, Simpson D, Singer EJ, Piliero PJ, Marra C, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623–625.
Delbue S, Pagani E, Guerini FR, Agliardi C, Mancuso R, Borghi E, Rossi F, Boldorini R, Veggiani C, Car PG, Ferrante P (2005a). Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J Med Virol 77: 447–454.
Delbue S, Sotgiu G, Fumagalli D, Valli M, Borghi E, Mancuso R, Marchioni E, Maserati R, Ferrante P (2005b). A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum and urine. J NeuroVirol 11: 51–57.
Di Giambenedetto S, Vago G, Pompucci A, Scoppettuolo G, Cingolani A, Marzocchetti A, Tumbarello M, Cauda R, De Luca A (2004). Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? Neurology 63: 2452–2453.
Du Pasquier RA, Schmitz JE, Jean Jacques J, Zheng Y, Gordon J, Khalili K, Letvin NL, Koralnik IJ (2004). Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol 78: 10206–10210.
Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E, Vago L, Boldorini R, Costanzi G (1995). PCR detection of JC virus DNA in brain tissue from patients with and without PML. J Med Virol 47: 219–225.
Ferrante P, Omodeo-Zorini E, Zuffolato MR, Mancuso R, Caldarelli-Stefano R, Puricelli S, Mediati M, Losciale L, Caputo D (1997). Human T cell lymphotropic virus tax and Epstein Barr virus DNA in peripheral blood of MS patients during acute attack. Acta Neurol Scand Suppl 169: 79–85.
Hoffmann C, Horst HA, Albrecht H, Schlote W (2003). Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiatry 74: 1142–1144.
Koralnik IJ (2004). New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 17: 365–370.
Koralnik IJ (2006). Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 60: 162–173.
Lyons AB, Parish CR (1994). Determination of lymphocyte division by flow cytometry. J Immunol Methods 171: 131–137.
Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, De Luca A (2005). Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 43: 4175–4177.
Mayo H, Collazos J, Martinez E (1998). Progressive multifocal leukoencephalopathy following initiation of highly antiretroviral therapy. AIDS 12: 1720–1722.
Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL (2002). Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 35: 1250–1257.
Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P (1995). Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171: 273–280.
Sipe JC, Knobler RL, Braheny SL, Rice GP, Panitch HS, Oldstone MB (1984). A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 34: 1368–1372.
Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F (2005). Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 109: 449–455.
Weber T, Turner RW, Frye S, Ruf B, Haas J, Schielke E, Pohle HD, Luke W, Luer W, Felgenhauer K (1994). Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 169: 1138–1141.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by NIH grant no. MH072528 and by grant from Italian Minister of Health (ISS 2004) to PF.
Rights and permissions
About this article
Cite this article
Delbue, S., Marchioni, E., Sotgiu, G. et al. Longitudinal study of two cases of progressive multifocal leukoencephalopathy with a clinical benign evolution. Journal of NeuroVirology 13, 268–273 (2007). https://doi.org/10.1080/13550280701291796
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280701291796